D C Tormey

4.4k total citations
55 papers, 3.6k citations indexed

About

D C Tormey is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D C Tormey has authored 55 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 21 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D C Tormey's work include Cancer Treatment and Pharmacology (27 papers), Breast Cancer Treatment Studies (18 papers) and Estrogen and related hormone effects (9 papers). D C Tormey is often cited by papers focused on Cancer Treatment and Pharmacology (27 papers), Breast Cancer Treatment Studies (18 papers) and Estrogen and related hormone effects (9 papers). D C Tormey collaborates with scholars based in United States, South Africa and United Kingdom. D C Tormey's co-authors include Richard Gray, Thomas J. Saphner, Geoffrey Falkson, Kennedy W. Gilchrist, Nancy F. Fritz, Martin D. Abeloff, Robert J. Gray, C. Kent Osborne, Geoffrey A. Mueller and Edward G. Mansour and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

D C Tormey

54 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D C Tormey United States	32	2.1k	1.1k	718	644	578	55	3.6k
M. Namer France	29	2.4k 1.2×	1.4k 1.2×	982 1.4×	612 1.0×	302 0.5×	122	3.7k
J.-C. Gazet United Kingdom	28	1.8k 0.9×	1.2k 1.1×	502 0.7×	685 1.1×	590 1.0×	59	3.2k
F. Cavalli Switzerland	33	2.2k 1.0×	652 0.6×	660 0.9×	463 0.7×	1.5k 2.5×	147	4.0k
A. Rubagotti Italy	32	1.6k 0.8×	1.2k 1.1×	934 1.3×	1.3k 2.0×	479 0.8×	131	3.7k
M. Bontenbal Netherlands	31	2.1k 1.0×	1.2k 1.1×	480 0.7×	667 1.0×	299 0.5×	66	3.4k
N. Tubiana-Mathieu France	30	2.0k 0.9×	630 0.6×	644 0.9×	200 0.3×	495 0.9×	166	3.2k
Diana Crivellari Italy	37	3.3k 1.6×	2.1k 1.8×	1.2k 1.6×	681 1.1×	736 1.3×	152	4.9k
Mark L. Graham United States	26	2.2k 1.0×	1.7k 1.5×	574 0.8×	1.1k 1.7×	741 1.3×	53	4.5k
Vincent Caggiano United States	23	2.5k 1.2×	1.8k 1.6×	579 0.8×	658 1.0×	603 1.0×	55	3.8k
Giuseppe D’Aiuto Italy	28	1.4k 0.7×	1.2k 1.1×	311 0.4×	533 0.8×	334 0.6×	90	2.8k

Countries citing papers authored by D C Tormey

Since Specialization

Citations

This map shows the geographic impact of D C Tormey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D C Tormey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D C Tormey more than expected).

Fields of papers citing papers by D C Tormey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D C Tormey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D C Tormey. The network helps show where D C Tormey may publish in the future.

Co-authorship network of co-authors of D C Tormey

This figure shows the co-authorship network connecting the top 25 collaborators of D C Tormey. A scholar is included among the top collaborators of D C Tormey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D C Tormey. D C Tormey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falkson, Geoffrey, Rebecca Gelman, K. J. Pandya, et al.. (1998). Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.. Journal of Clinical Oncology. 16(5). 1669–1676. 66 indexed citations

Mansour, Edward G., Robert J. Gray, Ahmad H. Shatila, et al.. (1998). Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.. Journal of Clinical Oncology. 16(11). 3486–3492. 66 indexed citations

Hansen, Richard M., Louise Ryan, Tom Anderson, et al.. (1996). Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal Cancer. JNCI Journal of the National Cancer Institute. 88(10). 668–674. 102 indexed citations

Falkson, Geoffrey, Christina Holcroft, Rebecca Gelman, et al.. (1995). Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study.. Journal of Clinical Oncology. 13(6). 1453–1458. 47 indexed citations

Elledge, Richard, Robert J. Gray, Edward G. Mansour, et al.. (1995). Accumulation of p53 Protein as a Possible Predictor of Response to Adjuvant Combination Chemotherapy With Cyclophosphamide, Methotrexate, Fluorouracil, and Prednisone for Breast Cancer. JNCI Journal of the National Cancer Institute. 87(16). 1254–1256. 85 indexed citations

Tormey, D C, R Gray, H. C. Falkson, et al.. (1993). Maintenance Tamoxifen After Induction Postoperative Chemotherapy in Node-Positive Breast Cancer Patients: The Eastern Cooperative Oncology Group Trials. Recent results in cancer research. 127. 185–196. 1 indexed citations

Borden, Ernest C., Kwang Taek Kim, Louise Ryan, et al.. (1992). Phase II Trials of Interferons-α and -β in Advanced Sarcomas. Journal of Interferon Research. 12(6). 455–458. 6 indexed citations

Allred, D. Craig, Gary M. Clark, Amol Tandon, et al.. (1992). HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.. Journal of Clinical Oncology. 10(4). 599–605. 385 indexed citations

Clark, Gary M., M. Mathieu, Marilyn A. Owens, et al.. (1992). Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.. Journal of Clinical Oncology. 10(3). 428–432. 97 indexed citations

10.

Hamm, John, D C Tormey, Peter Köhler, et al.. (1991). Phase I study of toremifene in patients with advanced cancer.. Journal of Clinical Oncology. 9(11). 2036–2041. 26 indexed citations

11.

Saphner, Thomas J., D C Tormey, & Richard Gray. (1991). Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.. Journal of Clinical Oncology. 9(2). 286–294. 319 indexed citations

12.

Jordan, V. Craig, Nancy F. Fritz, Susan M. Langan-Fahey, Mark E. Thompson, & D C Tormey. (1991). Alteration of Endocrine Parameters in Premenopausal Women With Breast Cancer During Long-Term Adjuvant Therapy With Tamoxifen as the Single Agent. JNCI Journal of the National Cancer Institute. 83(20). 1488–1491. 117 indexed citations

13.

Goldstein, Daniel A., Brigitte Cheuvart, D L Trump, et al.. (1990). Phase II Trial of Carboplatin in Soft-Tissue Sarcoma. American Journal of Clinical Oncology. 13(5). 420–423. 21 indexed citations

14.

Taylor, S G, Matthew Knuiman, Lynn A. Sleeper, et al.. (1989). Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.. Journal of Clinical Oncology. 7(7). 879–889. 44 indexed citations

15.

Tormey, D C. (1989). Endocrine Effects of Adjuvant Chemotherapy in Premenopausal Women: Suggestions for the Future. Recent results in cancer research. 115. 106–112. 1 indexed citations

16.

Bonomi, Philip, Dianne M. Finkelstein, John C. Ruckdeschel, et al.. (1989). Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.. Journal of Clinical Oncology. 7(11). 1602–1613. 278 indexed citations

17.

Fowble, Barbara, Robert J. Gray, Kennedy W. Gilchrist, et al.. (1988). Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.. Journal of Clinical Oncology. 6(7). 1107–1117. 172 indexed citations

18.

Grem, Jean L., K D Tutsch, Dona Alberti, et al.. (1987). Phase I study of taxol administered as a short i.v. infusion daily for 5 days.. PubMed. 71(12). 1179–84. 92 indexed citations

19.

Waalkes, T. Phillip & D C Tormey. (1978). Biologic markers and breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(4). 434–44. 14 indexed citations

20.

Whitcomb, Michael E., Michael Schwarz, & D C Tormey. (1972). Methotrexate pneumonitis: case report and review of the literature. Thorax. 27(5). 636–639. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact